The World Hepatitis Alliance is pleased to announce that, following a comprehensive interview process, Cary James has been selected as CEO and will start on April 8. Cary brings decades of experience in public health programmes and health policy at the national and international levels. He is a recognised leader in putting patients and communities at the centre of policy and programmes.
“I am excited for this opportunity to use my skills and experience to champion our members and people affected by viral hepatitis to make viral hepatitis elimination a reality,” Cary said.
Cary has worked extensively in hepatitis and HIV response, having developed innovative and successful campaigns and collaborated with numerous civil society organizations during his time as a member of the leadership team at the UK’s Terrence Higgins Trust. He has been a member of international advisory panels and expert groups on diagnostics, digital communications, health equality, hepatitis, HIV, tuberculosis and sexual health.
“Cary has a proven record of working closely with governmental and non-governmental organisations to tailor programmes to unique populations as well as high-level engagement with the WHO and UN, which are important skills in the work of the Alliance,” said WHA president Michael Ninburg.
Raquel Peck, senior advisor and former CEO of World Hepatitis Alliance, says she is delighted to be passing on the torch to Cary. “He will be a great fit for the organisation and an exciting appointment to drive the alliance forward.”
Dr.Su Wang has been appointed WHA president-elect, having served on the executive board of the WHA since 2014 as a regional representative for the PAHO region. Su is an internal medicine physician who discovered she had hepatitis B after donating blood in college and has used her own personal experience to advocate for the elimination of hepatitis. She worked in New York for many years, leading outreach and care programmes for hepatitis B patients, and now directs a number of hepatitis B and C programmes in her current role as medical director for the Center for Asian Health at Saint Barnabas Medical Center in New Jersey.
“Su has a long history of championing hepatitis B care in underserved populations and has been a strong advocate of expanding hepatitis B and C services to frontline providers,” Michael said. “She is a well-respected leader in the field and has also been an integral part of developing our NOhep Medical Visionaries programme. She is also a good friend.”
Su says she is honoured to have the opportunity to serve as president and continue the great work of the alliance in moving us towards elimination by 2030.”
As president-elect, Su will shadow current president Michael Ninburg until January 2020, when she will take up the role.
“I am thrilled with this next generation of leadership at the alliance. We are well-positioned for the next chapter in the race to eliminate viral hepatitis,” Michael said.
© The Hepatitis Foundation of New Zealand 2016